About Kinentia Biosciences
Kinentia Biosciences is a company based in Albany (United States) founded in 2007 by David Fairfax. It operates as a B2B. Kinentia Biosciences offers products and services including Deep Data Mining, Contract Research, Consulting Services, and Chemical Catalog. Kinentia Biosciences operates in a competitive market with competitors including Insitro, HotSpot Therapeutics, Certara, Inpharmatica and TOLREMO therapeutics, among others.
- Headquarter Albany, United States
- Founders David Fairfax
-
Sectors
Technology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kinentia Biosciences, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kinentia Biosciences
Kinentia Biosciences offers a comprehensive portfolio of products and services, including Deep Data Mining, Contract Research, Consulting Services, and Chemical Catalog.
Technology for risk mitigation in pharmaceutical drug discovery
Support for drug discovery and development activities
Expertise in CRO management and materials procurement
Collection of chemical intermediates and natural products
Funding Insights of Kinentia Biosciences
Detailed funding history for Kinentia Biosciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kinentia Biosciences
Investment portfolio details for Kinentia Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kinentia Biosciences
Detailed financials for Kinentia Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kinentia Biosciences Comparisons
Peer comparison for Kinentia Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kinentia Biosciences
Kinentia Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, HotSpot Therapeutics, Certara, Inpharmatica and TOLREMO therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Developer of a platform for protein function analysis
|
|
| Locked | Locked | Locked |
Provider of a platform for in silico drug discovery and consulting services
|
|
| Locked | Locked | Locked |
Developer of predictive informatics based platform for drug discovery
|
|
| Locked | Locked | Locked |
Anti-cancer small molecules are developed to target drug resistance pathways.
|
|
| Locked | Locked | Locked |
Immune system-based drugs are discovered via biological data analytics.
|
Detailed competitors of Kinentia Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kinentia Biosciences
Complete news archive for Kinentia Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kinentia Biosciences
Kinentia Biosciences was founded in 2007.
Kinentia Biosciences is headquartered in Albany, United States.
David Fairfax is the current CEO of Kinentia Biosciences. They have also founded this company.
Kinentia Biosciences, founded in 2007, utilizes Deep Data Mining technology to support clients in discovering and developing novel pharmaceutical agents by mitigating risks in the process. They offer contract research, manufacturing, and consulting services, including ADMET screening and global CRO management. Operating GLP and c-GMP facilities in the USA, the company is based in Rensselaer, New York, and serves pharmaceutical clients through in-house discovery to commercialization activities.
Kinentia Biosciences's top competitors include Insitro, HotSpot Therapeutics and Certara.
Kinentia Biosciences offers Deep Data Mining, Contract Research, Consulting Services, and Chemical Catalog.